These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 11748194

  • 1. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific.
    Fritz C, Maass S, Kreft A, Bange FC.
    Infect Immun; 2002 Jan; 70(1):286-91. PubMed ID: 11748194
    [Abstract] [Full Text] [Related]

  • 2. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice.
    Weber I, Fritz C, Ruttkowski S, Kreft A, Bange FC.
    Mol Microbiol; 2000 Mar; 35(5):1017-25. PubMed ID: 10712684
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis.
    Stermann M, Bohrssen A, Diephaus C, Maass S, Bange FC.
    J Clin Microbiol; 2003 Jul; 41(7):3252-9. PubMed ID: 12843072
    [Abstract] [Full Text] [Related]

  • 4. A promoter mutation causes differential nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium bovis.
    Stermann M, Sedlacek L, Maass S, Bange FC.
    J Bacteriol; 2004 May; 186(9):2856-61. PubMed ID: 15090527
    [Abstract] [Full Text] [Related]

  • 5. Differences in nitrate reduction between Mycobacterium tuberculosis and Mycobacterium bovis are due to differential expression of both narGHJI and narK2.
    Sohaskey CD, Modesti L.
    FEMS Microbiol Lett; 2009 Jan; 290(2):129-34. PubMed ID: 19076631
    [Abstract] [Full Text] [Related]

  • 6. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
    North RJ, Izzo AA.
    J Exp Med; 1993 Jun 01; 177(6):1723-33. PubMed ID: 8496688
    [Abstract] [Full Text] [Related]

  • 7. Histopathogenesis of experimental Mycobacterium bovis infection in mice.
    Chambers MA, Gavier-Widen D, Hewinson RG.
    Res Vet Sci; 2006 Feb 01; 80(1):62-70. PubMed ID: 15922378
    [Abstract] [Full Text] [Related]

  • 8. Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis.
    Sohaskey CD, Wayne LG.
    J Bacteriol; 2003 Dec 01; 185(24):7247-56. PubMed ID: 14645286
    [Abstract] [Full Text] [Related]

  • 9. Biochemical and immunological characterization of a cpn60.1 knockout mutant of Mycobacterium bovis BCG.
    Wang XM, Lu C, Soetaert K, S'Heeren C, Peirs P, Lanéelle MA, Lefèvre P, Bifani P, Content J, Daffé M, Huygen K, De Bruyn J, Wattiez R.
    Microbiology (Reading); 2011 Apr 01; 157(Pt 4):1205-1219. PubMed ID: 21127129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice.
    Hetland G, Løvik M, Wiker HG.
    Scand J Immunol; 1998 Jun 01; 47(6):548-53. PubMed ID: 9652822
    [Abstract] [Full Text] [Related]

  • 13. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H, Liu X, Lin C, Yang J, Chen F, Sun R, Zhang L, Liu J.
    Front Cell Infect Microbiol; 2017 Jun 01; 7():239. PubMed ID: 28642843
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urease activity does not contribute dramatically to persistence of Mycobacterium bovis bacillus Calmette-Guérin.
    Reyrat JM, Lopez-Ramirez G, Ofredo C, Gicquel B, Winter N.
    Infect Immun; 1996 Sep 01; 64(9):3934-6. PubMed ID: 8751954
    [Abstract] [Full Text] [Related]

  • 16. A single-nucleotide mutation in the -10 promoter region inactivates the narK2X promoter in Mycobacterium bovis and Mycobacterium bovis BCG and has an application in diagnosis.
    Chauhan S, Singh A, Tyagi JS.
    FEMS Microbiol Lett; 2010 Feb 01; 303(2):190-6. PubMed ID: 20041953
    [Abstract] [Full Text] [Related]

  • 17. A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice.
    Petricevich VL, Ueda C, Alves RC, da Silva MA, Moreno C, Melo AR, Dias da Silva W.
    Braz J Med Biol Res; 2001 Jan 01; 34(1):81-92. PubMed ID: 11151032
    [Abstract] [Full Text] [Related]

  • 18. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T.
    Vaccine; 2008 Feb 13; 26(7):924-32. PubMed ID: 18192091
    [Abstract] [Full Text] [Related]

  • 19. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA, Ramsay AJ, Buchan GS, Keen DL, Ranasinghe C, Slobbe L, Collins DM, de Lisle GW, Buddle BM.
    Immunology; 2003 Apr 13; 108(4):548-55. PubMed ID: 12667217
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.